REGENXBIO Inc. announced a conference call scheduled for November 5, 2026, to discuss its financial results for the third quarter ending September 30, 2026, along with operational highlights. The company, known for pioneering AAV gene therapy, is advancing treatments for rare and retinal diseases. Investors and analysts can join the webcast and Q&A session, with a replay available after the call. This event provides insight into REGENXBIO's progress and financial health as it continues developing innovative gene therapies.
REGENXBIO's upcoming Q3 2026 financial results call provides context for readers following gene therapy developments. For readers following the Health sector, here is Pluang's market snapshot as of Oct 29, 2026 17:11 WIB: out of 150 priced US Health stocks, 86 rose and 57 fell. Notable movers include Sana Biotechnology Inc (SANA) at USD 2.71 with a 3.04% gain and a typical hold time of 25 days, Gilead Sciences, Inc. (GILD) at USD 163.77 with an 87% buy order activity, and Vertex Pharmaceuticals Incorporated (VRTX) at USD 544.88 with a 2.87% rise and a 122-day typical hold time.
Dimensional Fund Advisors Ltd. disclosed holding a 5.07% stake in Vesuvius PLC ordinary shares as of October 28, 2026. The disclosure follows regulatory requirements under the Takeover Code, indicating significant interest in the company. Dimensional...
Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...
Katapult Holdings, a technology-driven platform serving nonprime consumers, announced it will release its third quarter 2026 financial results on November 12, 2026, before the market opens. The company will hold a conference call and webcast at 8:00 ...
Lulu's Fashion Lounge Holdings, Inc. announced it will report its third quarter 2026 financial results on November 12, 2026, after market close. The company will host a live webcast and conference call for investors at 5:00 p.m. Eastern Time the same...
RadNet, Inc. announced it will hold a conference call on November 9, 2026, at 7:30 a.m. Pacific Time to discuss its third quarter financial results. Investors can join via phone or webcast, with a replay available afterward. This call provides insigh...
